“Before the op, I would look at someone and all I could see for their face was blancmange,” says Jonathan Wyatt. “Now, I can see people’s faces.”
The 65-year-old is one of six people in the world to receive gene therapy for a rare type of inherited eye disease called choroideremia. The first published results of the trial, released today, suggest that tinkering with people’s genes can stop the disease from causing blindness – and restore sight in those whose vision has become impaired.
Read more on New Scientist
Abigail Beall 